RadarScreener › PHGE

PHGE

BiomX Inc.
NYSE · Biological Products, (No Diagnostic Substances) · EDGAR filings (CIK 1739174) · 11 signals · 0 setups · updated Aug 16, 2026

What the filings say Pressure ▼

The company can sell stock into the market any day at prevailing prices — steady supply.

Radar 67 (elevated attention) · dilution pressure high · listing risk elevated · governance risk elevated · runway 0.5 mo · strongest signal: Late filing (NT) (Aug 14, 2026)

Direction is stated for existing shareholders (▼ more shares / survival or listing risk; ▲ insiders or holders buying). It is a characterization of the filings, not a forecast or a recommendation.

67Radar · attention score (0–100)
84Dilution pressure · financing + balance sheet
56Listing risk · exchange standards
50Governance risk · reporting, auditor, going concern

Analyst note

No note yet. Notes are written each morning for the top-ranked setups; Pro subscribers get them in full the same day.

Pro on PHGE
Alerts
One email the morning PHGE files anything that matches your rules (types, minimum score, setups).
12-month history
Every signal and setup for PHGE back a year, not just 30 days — see how the current setup built.
Full analyst notes
What we noticed, evidence with links, what could prove us wrong, red-team caveats.
Full screener + CSV
All 985 flagged companies, same-day, sortable and exportable.
Get Pro · $18.85/mo founding rate   See a full Pro morning 35% off forever until Sept 30 · cancel any time

Balance sheet (XBRL)

$1.2Mcash + short-term investments as of Mar 31, 2026
0.5 moestimated runway (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts])
$-881Kstockholders' equity as of Mar 31, 2026
$11.9Mpublic float (10-K cover)
10.1Mshares outstanding as of May 20, 2026 · was 10.1M Apr 30, 2026

Runway = liquidity ÷ monthly operating burn at the latest reported period · balance sheet 138 days old. A financing after the balance-sheet date is the main reason a figure can be stale — check the timeline below for offerings since then.

Signal timeline

Last 30 days of filing signals plus current balance-sheet flags, newest first. ▼ pressure · ▲ support · hover a score for its components; every row links to the filing.

DateSignalEvidenceScore
Aug 14, 2026 Late filing (NT) NT 10-Q filed 2026-08-14 filing 50
Aug 11, 2026 Unregistered sale 8-K Item 3.02 filed 2026-08-11 (accepted 16:50 ET) filing 32
Aug 11, 2026 Reverse split “reverse split” language in 8-K (EX-10.1) filed 2026-08-11 filing 32
Aug 11, 2026 Reverse split “reverse split” language in DEF 14A (DEF 14A) filed 2026-08-11 filing 27
Jul 28, 2026 Unregistered sale 8-K Item 3.02 filed 2026-07-28 (accepted 09:15 ET) filing 32
Jul 27, 2026 Offering (424B) 424B5 prospectus supplement 2026-07-27; 3 prior 424B filings in 12m filing 46
Jul 27, 2026 ATM program “atm” language in 424B5 (424B5) filed 2026-07-27 filing 38
Jul 17, 2026 Reverse split “reverse split” language in PRE 14A (PRE 14A) filed 2026-07-17 filing 27
Mar 31, 2026 Runway < 6 months ~0.5 months runway: liquidity $1,168,000 as of 2026-03-31, burn $26,390,000/yr (latest fiscal-year operating cash flow (quarter too short to annualize) [companyfacts]) filing 44
Mar 31, 2026 Negative equity Stockholders' equity $-881,000 as of 2026-03-31 filing 31
Mar 31, 2026 Cash < current liabilities Liquidity $1,168,000 vs current liabilities $2,447,000 filing 21
Not a subscriber yet? The free morning digest carries what changed and the top setups. Subscribe free → · Compare plans